CA2569095A1 - Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof - Google Patents
Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof Download PDFInfo
- Publication number
- CA2569095A1 CA2569095A1 CA002569095A CA2569095A CA2569095A1 CA 2569095 A1 CA2569095 A1 CA 2569095A1 CA 002569095 A CA002569095 A CA 002569095A CA 2569095 A CA2569095 A CA 2569095A CA 2569095 A1 CA2569095 A1 CA 2569095A1
- Authority
- CA
- Canada
- Prior art keywords
- dpp
- computer
- amino acid
- coordinates
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57687704P | 2004-06-03 | 2004-06-03 | |
US60/576,877 | 2004-06-03 | ||
PCT/IB2005/001630 WO2005119526A1 (en) | 2004-06-03 | 2005-05-26 | Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2569095A1 true CA2569095A1 (en) | 2005-12-15 |
Family
ID=34969993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002569095A Abandoned CA2569095A1 (en) | 2004-06-03 | 2005-05-26 | Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1756740A1 (de) |
CA (1) | CA2569095A1 (de) |
MX (1) | MXPA06014083A (de) |
WO (1) | WO2005119526A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
BRPI0711558A2 (pt) | 2006-05-04 | 2011-11-08 | Boeringer Ingelheim Internat Gmbh | polimorfos |
EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
CA2753884A1 (en) * | 2009-02-27 | 2010-09-02 | Trustees Of Tufts College | Soft protease inhibitors, and pro-soft forms thereof |
US8716482B2 (en) * | 2009-09-25 | 2014-05-06 | Merck Sharp & Dohme Corp. | Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
EP2366394A1 (de) * | 2010-03-17 | 2011-09-21 | IMTM GmbH | Charakterisierung und Validierung von Inhibitoren und Liganden der Dipeptidyl-Aminopeptidase IV (DP IV) |
US8980929B2 (en) | 2010-05-21 | 2015-03-17 | Merck Sharp & Dohme Corp. | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
EP2600888A2 (de) * | 2010-08-03 | 2013-06-12 | Cadila Pharmaceuticals Ltd. | Neue verbindungen als dpp-iv-inhibitoren und verfahren zu ihrer herstellung |
AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
-
2005
- 2005-05-26 CA CA002569095A patent/CA2569095A1/en not_active Abandoned
- 2005-05-26 WO PCT/IB2005/001630 patent/WO2005119526A1/en not_active Application Discontinuation
- 2005-05-26 MX MXPA06014083A patent/MXPA06014083A/es unknown
- 2005-05-26 EP EP05744309A patent/EP1756740A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1756740A1 (de) | 2007-02-28 |
WO2005119526A1 (en) | 2005-12-15 |
MXPA06014083A (es) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005113762A1 (en) | CRYSTAL STRUCTURE OF PROTEIN KINASE B-α (AKT-1) AND USES THEREOF | |
US20050075795A1 (en) | Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE1B) and uses thereof | |
US20080215249A1 (en) | Crystallization and structure determination of beta secretase and/or beta secretase-like proteins | |
US7829303B1 (en) | Ligand screening method using a crystal of beta secretase | |
CA2569095A1 (en) | Crystal structure of dipeptidyl peptidase iv (dpp-iv) and uses thereof | |
US20040171019A1 (en) | PIN1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design | |
US20050202550A1 (en) | Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof | |
US20070032403A1 (en) | Crystal structure of the ITK kinase domain | |
EP1265927B1 (de) | Kristall | |
US20030165984A1 (en) | Hepatitis C virus helicase crystals, crystallographic structure and methods | |
EP1301536B1 (de) | Modulation der tetraspanin funktion | |
US20080064052A1 (en) | Crystal of a Receptor-Ligand Complex and methods of use | |
US20250027060A1 (en) | Crystal Structures of ALK and LTK Receptor Tyrosine Kinases and Their Ligands | |
AU781654B2 (en) | Crystallization and structure determination of staphylococcus aureus thymidylate kinase | |
US20060234293A1 (en) | Polypeptide methods and means | |
EP1393235A1 (de) | Kristallisiertes polypeptid der liganden bindungsdomäne des menschlichen xenobiotischen nuklearen rezeptors pxr/sxr sowie dieses verwendende screening-verfahren | |
US7297508B1 (en) | Crystallization of fibroblast activation protein alpha (FAPα) | |
US20080020984A1 (en) | Crystal Structure of a Receptor-Ligand Complex and Methods of Use | |
US7507552B1 (en) | Crystallization of histone deacetylase 2 | |
US20050131209A1 (en) | Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same | |
WO2005119525A1 (en) | 11βHSD1 CRYSTAL STRUCTURES FOR STRUCTURE BASED DRUG DESIGN | |
WO2005103241A1 (en) | Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase 9a (pde9a) and uses thereof | |
MXPA06009940A (en) | Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase (pde10a) and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued | ||
FZDE | Discontinued |
Effective date: 20090526 |